Risks of hydroxyethyl starch 130/0.4 in cardiac surgery

J Pharm Pract. 2014 Feb;27(1):17-8. doi: 10.1177/0897190013504960.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Cardiac Surgical Procedures / methods*
  • Formularies, Hospital as Topic
  • Humans
  • Hydroxyethyl Starch Derivatives / administration & dosage
  • Hydroxyethyl Starch Derivatives / adverse effects*
  • Hydroxyethyl Starch Derivatives / chemistry
  • Plasma Substitutes / administration & dosage
  • Plasma Substitutes / adverse effects*
  • Plasma Substitutes / chemistry

Substances

  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes